Literature DB >> 24608986

SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.

Saskia A Graf1, Christian Busch2, Anja-Katrin Bosserhoff3, Robert Besch1, Carola Berking4.   

Abstract

The transcription factor SOX10 (SRY (sex determining region Y)-box 10) has a key role in the embryonic development of melanocytes. Recently, it has been suggested that SOX10 is highly relevant for melanoma development and survival. However, the distinct functions and downstream targets of SOX10 in melanoma remain widely unknown. In this study, we inhibited SOX10 via RNA interference in different human melanoma cell lines and found a significantly reduced invasion capacity in vitro and in the chick embryo model. At later time points, SOX10 inhibition reduced proliferation and induced cell death. We identified melanoma inhibitory activity (MIA) as a direct target gene of SOX10, which is an essential protein for melanoma cell migration and invasion. Expression levels of SOX10 and MIA strictly correlated in melanoma cell lines, and SOX10 inhibition reduced MIA expression and promoter activity. Direct binding of SOX10 to the MIA promoter was demonstrated by electrophoretic mobility shift assay and chromatin immunoprecipitation. Ectopic expression of MIA in SOX10-inhibited melanoma cells restored the invasion capacity, supporting the hypothesis that MIA is responsible for SOX10-mediated melanoma cell invasion. Our data provide evidence for a critical role of SOX10 in melanoma cell invasion through the regulation of MIA and highlight its role as a therapeutic target in melanoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24608986     DOI: 10.1038/jid.2014.128

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  37 in total

Review 1.  Sox proteins in melanocyte development and melanoma.

Authors:  Melissa L Harris; Laura L Baxter; Stacie K Loftus; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-22       Impact factor: 4.693

2.  Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma.

Authors:  Olga Shakhova; Daniel Zingg; Simon M Schaefer; Lisette Hari; Gianluca Civenni; Jacqueline Blunschi; Stéphanie Claudinot; Michal Okoniewski; Friedrich Beermann; Daniela Mihic-Probst; Holger Moch; Michael Wegner; Reinhard Dummer; Yann Barrandon; Paolo Cinelli; Lukas Sommer
Journal:  Nat Cell Biol       Date:  2012-07-08       Impact factor: 28.824

3.  Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin.

Authors:  C Berking; R Takemoto; K Satyamoorthy; R Elenitsas; M Herlyn
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.

Authors:  Anne-Lise Steunou; Manuelle Ducoux-Petit; Ikrame Lazar; Bernard Monsarrat; Monique Erard; Catherine Muller; Eric Clottes; Odile Burlet-Schiltz; Laurence Nieto
Journal:  Mol Cell Proteomics       Date:  2012-12-28       Impact factor: 5.911

5.  Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma.

Authors:  A K Bosserhoff; S Kondo; M Moser; U H Dietz; N G Copeland; D J Gilbert; N A Jenkins; R Buettner; L J Sandell
Journal:  Dev Dyn       Date:  1997-04       Impact factor: 3.780

6.  Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.

Authors:  Robert Besch; Hendrik Poeck; Tobias Hohenauer; Daniela Senft; Georg Häcker; Carola Berking; Veit Hornung; Stefan Endres; Thomas Ruzicka; Simon Rothenfusser; Gunther Hartmann
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

7.  Frequent mutations in the MITF pathway in melanoma.

Authors:  Julia C Cronin; John Wunderlich; Stacie K Loftus; Todd D Prickett; Xiaomu Wei; Katie Ridd; Swapna Vemula; Allison S Burrell; Neena S Agrawal; Jimmy C Lin; Carolyn E Banister; Phillip Buckhaults; Steven A Rosenberg; Boris C Bastian; William J Pavan; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2009-04-29       Impact factor: 4.693

8.  Sox10: a pan-schwannian and melanocytic marker.

Authors:  Daisuke Nonaka; Luis Chiriboga; Brian P Rubin
Journal:  Am J Surg Pathol       Date:  2008-09       Impact factor: 6.394

9.  The tyrosinase enhancer is activated by Sox10 and Mitf in mouse melanocytes.

Authors:  Fabien Murisier; Sabrina Guichard; Friedrich Beermann
Journal:  Pigment Cell Res       Date:  2007-06

10.  The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival.

Authors:  Tobias Hohenauer; Carola Berking; Andreas Schmidt; Sebastian Haferkamp; Daniela Senft; Claudia Kammerbauer; Sabine Fraschka; Saskia Anna Graf; Martin Irmler; Johannes Beckers; Michael Flaig; Achim Aigner; Sabrina Höbel; Franziska Hoffmann; Heiko Hermeking; Simon Rothenfusser; Stefan Endres; Thomas Ruzicka; Robert Besch
Journal:  EMBO Mol Med       Date:  2013-05-13       Impact factor: 12.137

View more
  36 in total

1.  High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.

Authors:  Philip Eliades; Brian J Abraham; Zhenyu Ji; David M Miller; Camilla L Christensen; Nicholas Kwiatkowski; Raj Kumar; Ching Ni Njauw; Michael Taylor; Benchun Miao; Tinghu Zhang; Kwok-Kin Wong; Nathanael S Gray; Richard A Young; Hensin Tsao
Journal:  J Invest Dermatol       Date:  2018-02-08       Impact factor: 8.551

2.  The expression of melanoma inhibitory activity on mast cells in child patients with cutaneous mastocytosis.

Authors:  Yuko Ehara; Yuichi Yoshida; Makoto Tahira; Osamu Yamamoto
Journal:  Yonago Acta Med       Date:  2014-10-15       Impact factor: 1.641

3.  A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma.

Authors:  Ahmad A Tarhini; Theofanis Floros; Hui-Min Lin; Yan Lin; Zahra Rahman; Madeeha Ashraf; Priyanka Vallabhaneni; Cindy Sander; Uma N M Rao; Monica Panelli; William A LaFramboise; John M Kirkwood
Journal:  Melanoma Res       Date:  2017-10       Impact factor: 3.599

Review 4.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

5.  A Quantitative System for Studying Metastasis Using Transparent Zebrafish.

Authors:  Silja Heilmann; Kajan Ratnakumar; Erin Langdon; Emily Kansler; Isabella Kim; Nathaniel R Campbell; Elizabeth Perry; Amy McMahon; Charles Kaufman; Ellen van Rooijen; William Lee; Christine Iacobuzio-Donahue; Richard Hynes; Leonard Zon; Joao Xavier; Richard White
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701

6.  Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells.

Authors:  Christopher Dravis; Benjamin T Spike; J Chuck Harrell; Claire Johns; Christy L Trejo; E Michelle Southard-Smith; Charles M Perou; Geoffrey M Wahl
Journal:  Cell Rep       Date:  2015-09-10       Impact factor: 9.423

Review 7.  Developmental pathways activated in melanocytes and melanoma.

Authors:  Jianglan Liu; Mizuho Fukunaga-Kalabis; Ling Li; Meenhard Herlyn
Journal:  Arch Biochem Biophys       Date:  2014-08-08       Impact factor: 4.013

8.  UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling.

Authors:  Anushka Dikshit; Yingai J Jin; Simone Degan; Jihwan Hwang; Matthew W Foster; Chuan-Yuan Li; Jennifer Y Zhang
Journal:  Cancer Res       Date:  2018-09-17       Impact factor: 12.701

9.  A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation.

Authors:  Charles K Kaufman; Christian Mosimann; Zi Peng Fan; Song Yang; Andrew J Thomas; Julien Ablain; Justin L Tan; Rachel D Fogley; Ellen van Rooijen; Elliott J Hagedorn; Christie Ciarlo; Richard M White; Dominick A Matos; Ann-Christin Puller; Cristina Santoriello; Eric C Liao; Richard A Young; Leonard I Zon
Journal:  Science       Date:  2016-01-28       Impact factor: 47.728

Review 10.  How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.

Authors:  Anja Wessely; Theresa Steeb; Carola Berking; Markus Vincent Heppt
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.